ARCHIVES

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 31 | August 4, 1995

Download PDF Visit The Full Archive

Related Articles

Rosenberg Starts New Study With TIL; LAK-IL-2 Costs Clarified

November 28, 1986

Upton Leaning to New Division for Centers, Organ Sites, Education

August 25, 1978

Report Urges Enhancement Of Cancer Data Systems.

October 20, 2000

Patient Advocacy: Policy Should Prevent Employers From Using Genetic Test Results

April 11, 1997

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

Roswell Park Celebrates 50th Anniversary of Pivotal Congressional Visit

October 20, 2021